Carol Collins

Drug–Drug Interaction Potential of Marketed Oncology Drugs: In Vitro Assessment of Time-Dependent Cytochrome P450 Inhibition, Reactive Metabolite Formation and Drug–Drug Interaction Prediction

Jane R. Kenny, Sophie Mukadam, Chenghong Zhang et al. · Pharmaceutical Research · 2012 · 94 citations

Medicine, Pharmacokinetics, Pharmacology +17

Designing mobile support for glycemic control in patients with diabetes

Lynne T. Harris, James T. Tufano, Tung Thanh Le et al. · Journal of Biomedical Informatics · 2010 · 60 citations

Medicine, Biomedical Informatics, Health Informatics +14

Long-acting combination anti-HIV drug suspension enhances and sustains higher drug levels in lymph node cells than in blood cells and plasma

John C. Kraft, Lisa A. McConnachie, Josefin Koehn et al. · AIDS · 2017 · 50 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Quantitative characterization of UDP-glucuronosyltransferase 2B17 in human liver and intestine and its role in testosterone first-pass metabolism

Haeyoung Zhang, Abdul Basit, Diana Busch et al. · Biochemical Pharmacology · 2018 · 49 citations · Full text

Life Sciences, Biochemistry, Pharmacokinetics +14

Mechanism-based pharmacokinetic (MBPK) models describe the complex plasma kinetics of three antiretrovirals delivered by a long-acting anti-HIV drug combination nanoparticle formulation

John C. Kraft, Lisa A. McConnachie, Josefin Koehn et al. · Journal of Controlled Release · 2018 · 48 citations

Pharmacy, Pharmacokinetics, Pharmacology +14